{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:48:05Z","timestamp":1740170885660,"version":"3.37.3"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:00:00Z","timestamp":1606521600000},"content-version":"vor","delay-in-days":393,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Infectious Disease Clinical Research Program"},{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Preventive Medicine and Biostatistics through a cooperative agreement"},{"name":"Advancement of Military Medicine, Inc"},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HT9404-12-1-0019"],"award-info":[{"award-number":["HT9404-12-1-0019"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Y1-AI-5072"],"award-info":[{"award-number":["Y1-AI-5072"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Armed Forces Health Surveillance Branch, Global Emerging Infections Surveillance"},{"DOI":"10.13039\/100012399","name":"Biomedical Advanced Research and Development Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012399","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Navy Bureau of Medicine and Surgery"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Acute respiratory infections (ARI) result in substantial annual morbidity among military personnel and decrease operational readiness. Herein, we summarize the research efforts of the Infectious Disease Clinical Research Program (IDCRP) related to ARIs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The ARI Research Area of the IDCRP was established in response to the 2009 emergence of pandemic influenza A\/H1N1. That year, IDCRP investigators deployed the ARI Consortium Natural History Study (ARIC NHS), a multi-centered, longitudinal observational study to assess etiology, epidemiology, and clinical characteristics of influenza-like illness (ILI) and severe acute respiratory infections (SARI) in the U.S. military. The success of this initial effort spurred implementation of several new initiatives. These include the FluPlasma trial, designed to evaluate the efficacy of hyperimmune anti-influenza plasma for the treatment of severe influenza; the self-administered live-attenuated influenza vaccine (SNIF) trial, which assessed the immunogenicity and acceptance of a self-administered live-attenuated influenza vaccine in military personnel; the Study to Address Threats of ARI in Congregate Military Populations (ATARI), a prospective study of ILI transmission, etiology and epidemiology in recruits; and the Flu Breath Test (FBT) study, a preliminary study of exhaled volatile organic compounds (VOC) in influenza patients. In addition, the InFLUenza Patient-Reported Outcome (FLU-PRO) survey, a daily diary to measure influenza symptoms during clinical trials, was developed. Lastly, the Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED) study, a two-year randomized trial designed to compare the effectiveness of the three types of licensed vaccines, launched in Fall 2018.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The on-going ARIC NHS has enrolled over 2000 ILI and SARI cases since its inception, providing data on burden and clinical manifestations of ARI in military personnel and their families. The FluPlasma 2 trial concluded subject enrollment in 2018. Preliminary results from ATARI study show a high frequency of respiratory viruses circulating during the first two weeks of recruit training. Based on assessment of FLU-PRO responses, which were found to be reliable and reproducible, the survey may be a useful tool in clinical trials and epidemiological studies. The Flu Breath Study will complete enrollment in 2019. Findings from PAIVED are intended to provide evidence needed for assessing influenza vaccination policy in the military.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The ARI burden in the armed services remains significant every year and the threat is dynamic given emergent and evolving threats, such as influenzas. With strong successes to date, future initiatives of the ARI Research Area will focus on interventional studies, ARI transmission dynamics in congregate military settings, and determinants of risk of pandemic influenza and other emergent respiratory viruses.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/milmed\/usz174","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T13:11:14Z","timestamp":1574946674000},"page":"44-50","source":"Crossref","is-referenced-by-count":8,"title":["The Acute Respiratory Infection Consortium: A Multi-Site, Multi-Disciplinary Clinical Research Network in the Department of Defense"],"prefix":"10.1093","volume":"184","author":[{"given":"Christian","family":"Coles","sequence":"first","affiliation":[{"name":"Infectious Disease Clinical Research Program, Preventive Medicine & Biostatistics Department, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814"},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene V","family":"Millar","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Preventive Medicine & Biostatistics Department, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814"},{"name":"Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Burgess","sequence":"additional","affiliation":[{"name":"Infectious Disease Clinical Research Program, Preventive Medicine & Biostatistics Department, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin G","family":"Ottolini","sequence":"additional","affiliation":[{"name":"Preventive Medicine & Biostatistics Department, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,11,28]]},"reference":[{"volume-title":"Center for Military History. The Army Medical Department 1775\u20131818","year":"2002","author":"Gillett","key":"2020120619053577700_usz174C1"},{"key":"2020120619053577700_usz174C2","first-page":"1","volume-title":"Internal Medicine in World War II. Volume II. Infectious Diseases","author":"Kneeland","year":"1963"},{"issue":"8","key":"2020120619053577700_usz174C3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1749-6632.1957.tb46049.x","article-title":"Epidemiology of adenovirus respiratory infections in military recruit populations","volume":"67","author":"Hilleman","year":"1957","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2020120619053577700_usz174C4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/oxfordjournals.aje.a121306","article-title":"Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines","volume":"94","author":"Top","year":"1971","journal-title":"Am J Epidemiol"},{"issue":"3","key":"2020120619053577700_usz174C5","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1128\/CMR.00039-14","article-title":"Respiratory infections in the U.S. Military: recent experience and control","volume":"28","author":"Sanchez","year":"2015","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"2020120619053577700_usz174C6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1186\/s12879-014-0576-2","article-title":"Retrospective analysis of demographic and clinical factors associated with etiology of febrile respiratory illness among US military basic trainees","volume":"14","author":"Padin","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"7","key":"2020120619053577700_usz174C7","doi-asserted-by":"crossref","first-page":"e6177","DOI":"10.1371\/journal.pone.0006177","article-title":"Self reported incidence and morbidity of acute respiratory illness among deployed U.S. military in Iraq and Afghanistan","volume":"4","author":"Soltis","year":"2009","journal-title":"PLoS One"},{"issue":"5","key":"2020120619053577700_usz174C8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/irv.12392","article-title":"Type-specific clinical characteristics of adenovirus-associated influenza-like illness at five US military medical centers, 2009\u20132014","volume":"10","author":"Koren","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"issue":"7 Suppl 2","key":"2020120619053577700_usz174C9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/milmed\/165.suppl_2.32","article-title":"The Naval Health Research Center Respiratory Disease Laboratory","volume":"165","author":"Ryan","year":"2000","journal-title":"Mil Med"},{"issue":"2","key":"2020120619053577700_usz174C10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/milmed\/162.2.82","article-title":"Meeting the challenge of emerging pathogens: the role of the United States Air Force in global influenza surveillance","volume":"162","author":"Williams","year":"1997","journal-title":"Mil Med"},{"year":"2014","author":"World Health Organization","key":"2020120619053577700_usz174C11"},{"key":"2020120619053577700_usz174C12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcv.2015.01.007","article-title":"Epidemiologic, clinical, and virologic characteristics of human rhinovirus infection among otherwise healthy children and adults: rhinovirus among adults and children","volume":"64","author":"Chen","year":"2015","journal-title":"J Clin Virol"},{"issue":"2","key":"2020120619053577700_usz174C13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/irv.12538","article-title":"Species-specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults","volume":"12","author":"Bouvier","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"2020120619053577700_usz174C14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-015-1330-0","article-title":"Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenza","volume":"16","author":"Powers","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"3","key":"2020120619053577700_usz174C15","doi-asserted-by":"crossref","first-page":"e0194180","DOI":"10.1371\/journal.pone.0194180","article-title":"Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI)","volume":"13","author":"Powers","year":"2018","journal-title":"PLoS One"},{"key":"2020120619053577700_usz174C16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcv.2015.03.018","article-title":"Neuraminidase inhibitor therapy in a military population","volume":"67","author":"Fairchok","year":"2015","journal-title":"J Clin Virol"},{"issue":"suppl 1","key":"2020120619053577700_usz174C17","doi-asserted-by":"crossref","first-page":"S585","DOI":"10.1093\/ofid\/ofx163.1531","article-title":"Etiology and clinical characteristics of influenza-like illness in healthy adults by hospitalization status","volume":"4","author":"Maves","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"suppl 1","key":"2020120619053577700_usz174C18","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1093\/ofid\/ofx163.516","article-title":"Burden of influenza-like illness among military personnel receiving advanced training at Ft. Sam Houston, TX","volume":"4","author":"Chen","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"suppl 1","key":"2020120619053577700_usz174C19","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.1093\/ofid\/ofx163.724","article-title":"Study to Address Threats of Acute Respiratory Infections among Congregate Military Populations (ATARI)","volume":"4","author":"Coles","year":"2017","journal-title":"Open Forum Infect Dis"},{"issue":"suppl 1","key":"2020120619053577700_usz174C20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/ofid\/ofw172.105","article-title":"Comparative evaluation of Diatherix target enriched multiplex polymerase chain reaction and BioFire FilmArray in the detection of viral and bacterial respiratory pathogens","volume":"3","author":"Chen","year":"2016","journal-title":"Open Forum Infect Dis"},{"author":"Miller","key":"2020120619053577700_usz174C21"},{"key":"2020120619053577700_usz174C22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fgene.2014.00080","article-title":"How integration of global omics-data could help preparing for pandemics - a scent of influenza","volume":"5","author":"Bos","year":"2014","journal-title":"Front Genet"},{"issue":"1","key":"2020120619053577700_usz174C23","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.3390\/s17010199","article-title":"Novel isoprene sensor for a Flu virus breath monitor","volume":"17","author":"Gouma","year":"2017","journal-title":"Sensors"},{"issue":"12","key":"2020120619053577700_usz174C24","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/bmc.3494","article-title":"Volatile organic compounds generated by cultures of bacteria and viruses associated with respiratory infections","volume":"29","author":"Abd El Qader","year":"2015","journal-title":"Biomed Chromatogr"},{"issue":"5","key":"2020120619053577700_usz174C25","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.vaccine.2018.12.006","article-title":"Estimating influenza vaccine effectiveness using data routinely available in electronic primary care records","volume":"37","author":"Regan","year":"2019","journal-title":"Vaccine"},{"key":"2020120619053577700_usz174C26","article-title":"Influenza vaccine effectiveness in the United States during the 2016\u20132017 season","author":"Flannery","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"43","key":"2020120619053577700_usz174C27","doi-asserted-by":"crossref","first-page":"1700732","DOI":"10.2807\/1560-7917.ES.2018.23.43.1700732","article-title":"Influenza vaccine effectiveness in reducing severe outcomes over six influenza seasons, a case-case analysis, Spain, 2010\/11 to 2015\/16","volume":"23","author":"Godoy","year":"2018","journal-title":"Euro Surveill"},{"key":"2020120619053577700_usz174C28","article-title":"Influenza vaccine effectiveness","author":"Ferdinands","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"32","key":"2020120619053577700_usz174C29","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1016\/j.vaccine.2015.06.061","article-title":"Self-administration of intranasal influenza vaccine: Immunogenicity and volunteer acceptance","volume":"33","author":"Burgess","year":"2015","journal-title":"Vaccine"},{"issue":"17","key":"2020120619053577700_usz174C30","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/j.vaccine.2011.02.040","article-title":"Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults","volume":"29","author":"Crum-Cianflone","year":"2011","journal-title":"Vaccine"},{"issue":"51","key":"2020120619053577700_usz174C31","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1016\/j.vaccine.2015.11.004","article-title":"Vaccine-associated reduction in symptom severity among patients with influenza A\/H3N2 disease","volume":"33","author":"Deiss","year":"2015","journal-title":"Vaccine"},{"issue":"suppl 1","key":"2020120619053577700_usz174C32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ofid\/ofv133.365","article-title":"Estimates of influenza vaccine effectiveness among highly immunized United States military members and beneficiaries: utilization of propensity score matching","volume":"2","author":"Coles","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"2020120619053577700_usz174C33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2017.1334554","article-title":"Repeated annual influenza vaccination and vaccine effectiveness: review of evidence","volume":"16","author":"Belongia","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"2020120619053577700_usz174C34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41541-018-0079-z","article-title":"Cell culture-derived influenza vaccines in the severe 2017\u20132018 epidemic season: a step towards improved influenza vaccine effectiveness","volume":"3","author":"Barr","year":"2018","journal-title":"NPJ Vaccines"},{"issue":"36","key":"2020120619053577700_usz174C35","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/j.vaccine.2015.06.090","article-title":"Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1\u20133 April 2014","volume":"33","author":"Ampofo","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"2020120619053577700_usz174C36","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S2213-2600(17)30174-1","article-title":"Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study","volume":"5","author":"Beigel","year":"2017","journal-title":"Lancet Respir Med"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/184\/Supplement_2\/44\/33201218\/usz174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/184\/Supplement_2\/44\/33201218\/usz174.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:20:49Z","timestamp":1607300449000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/184\/Supplement_2\/44\/5645086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":36,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2019,11,28]]},"published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usz174","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"type":"print","value":"0026-4075"},{"type":"electronic","value":"1930-613X"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,11,1]]}}}